Condition
Facial Wrinkles and Rhytides Reduction
Total Trials
5
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07526870Not ApplicableCompleted
Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement
NCT07160777Active Not Recruiting
Performance and Safety of Semical Dermal Fillers in Facial Rejuvenation
NCT07067086Not ApplicableCompletedPrimary
Cream Short-term Efficacy Clinical Study
NCT06724510Not ApplicableRecruiting
Safety and Efficacy Evaluation of High Intensity Focused Ultrasound Device in Eyebrow Lifting
NCT01559233Not ApplicableCompletedPrimary
Clinical Study to Determine Safety and Efficacy of FPlus for Wrinkle Treatment
Showing all 5 trials